- Hong Kong stock medical and industrial sectors are accelerating international expansion through overseas certifications, product approvals, and strategic financing to counter collection pressures.
- Companies like Star Biotech, CStone Pharmaceuticals, and Ascentage Pharma achieved significant milestones in 2026, including EU CE MDR certification, UK MHRA approval, and US FDA/EMA approvals alongside fundraising initiatives.
- Meanwhile, firms such as WEGO Group, Angelalign, and other enterprises advanced business integrations, overseas expansions, share buybacks, or strategic pivots toward AI energy storage.